Brown tumor ; an uncommonfocal giant-cell lesion, arises as a direct result ofthe effect ofparathyroid hormone on bone tissue inpatients with hyperparathyroidism. The initial treatment involves the correction ofhyperparathyroidism, which usually leads to tumor regression. We report a case ofbrown tumor ofthe right nasal fossa in a 71-year-old woman. The tumor had caused nasal obstruction and epistax is. Laboratory evaluation revealed that the patient hadprimary hyperparathyroidism . Anatomicopathologic investigation revealed the presence ofa giant-cell tumor:
Introduction
Brown tumor, an uncommon focal giant-cell lesion, arises as a direct result of the effect of parathyroid hormone on bone tissue in some patients with hyperparathyroidism. Brown tumors can affect the mandible, maxilla , clavicle, ribs, and pelvic bones.' Radiographic and histologic changes associated with the presence of this lesion may be very similar to those of other bone lesions of the face. Therefore, the diagnosis requires a systemic investigation for lesion differentiation. From We report a case of brown tumor in an elderly woman, and we discuss the clinical history, differential diagnosis , diagnosis, and treatment of this type oflesion.
Case report
A 71-year-old woman was referred to ourotorhinolaryngology service for evaluation of a painful mass in the right nasal fossa that had developed I month earlier. The size of the mass had progressively increased and had eventually caused nasal obstruction and epistaxis . Six years earlier, the patient had presented with a nodule in the right mandibular region. At that time, she underwent an excisional biopsy and hemimandibulectomy, and the mass was diagnosed histologically as a giant-cell tumor. Until the development of the new mass, she had remained asymptomatic. She had not been evaluated for hyperparathyroidism during her previous episode.
Otorhinolaryngologic examination revealed that the mass had caused a septal deviation to the left. Oroscopy identified a bulge in the right upper gingival-labial sulcus . Computed tomography (CT) of the paranasal sinuses revealed a dense area in the right nasal fossa (figure 1). No bone erosion was evident. Biopsy of the mass revealed that it was a giant-cell tumor.
Laboratory evaluation revealed that the patient had primary hyperparathyroidism, as her parathyroid hormone level was 988 pg/ml (normal : 12 to 72). Other laboratory measurements were total serum calcium, 11.2 mg/dl (normal : 8.8 to 11.0); ionized calcium , 5.6 mg/dl (normal: 4.0 to 5.4); phosphorus, 2.0 mg/dl (normal: 2.5 to 4.8); and alkaline phosphatase, 145 U/L (normal: 32 to 104). Ultrasonography of the neck revealed an enlargement of the lower left parathyroid gland (2.1 x 1.4 x 0.8 ern) , The finding of hyperparathyroidism confirmed the diagnosis of brown tumor.
To correct the hormonal imbalance, we performed a partial parathyroidectomy with a self-implantation of the right lower parathyroid into the prethyroid muscles . in the right nasal fossa failed to regress and the pat ient's nasal symptoms persisted. Therefore, she underwent exeresis of the mass through a sublabial incision. Intraoperatively, the mass appeared as a hard, brownish-white, well-delimited, 2.5 x 1.2 x I .I -cm lesion that extended into the upper portion of the hard palate. Curettage ofthe palatine bone was also performed. Anatomicopathologic examination revealed that the fibrous lesion contained numerous giant cells, again confirming our diagnosis of brown tumor. The patient recovered uneventfully, and she remained asymptomatic and recurrence-free at the I-year follow -up (figure 2).
Discussion
Brown tumor is an uncommon sequela ofhyperparathyroidism.The lesion localizes in areas ofintense bone resorption, and the bone defect becomes filled with fibroblastic tissue that can deform the bone and simulate a neoplastic process.' These tumors have a brown or yellow hue.'
Brown tumors arise secondary to both primary and secondary hyperparathyroidism. They have been reported to occur in 4.5% ofpatients with primary hyperparathyroidism and 1.5 to 1.7% ofthose with secondary disease .l-' Hyperparathyroidism is frequently caused by the development of a parathyroid adenoma and less often by hyperplasia or a carcinoma. Some parathyroid adenomas and hyperplasias are familial (5% of cases), and others are part of mu ltiple type I, lIa, and lIb endocrine neoplasias . The size of a parathyroid adenoma is correlated with the level of parathyroid hormone in blood.' Anatomicopathologic study of the parathyroid in our patient revea led the presence of an adenoma.
Albright et ai, in their classic description of primary hyperparathyroidism, reported that 2 of 17 patients (11.8%) had tumors involving the jaws."In a review of220 patients, Rosenberg and Guralnick found that 10 patients (4.5%) had a mass involving one or both jaws as their presenting complaint.' Brown tumors arise more frequently in the mandible than in the maxilla.P Our patient originally had a brown tumor in the mandible and later in the right nasal fossa.
The reported prevalence of brown tumor is 0.1%. 2 The disease can manifest at any age, but it is more common among persons older than 50 years .' It is three times more common in women than in men.' Our patie nt was 65 years old the first time she was diagnosed with a giantcell tumor.
Most patients with hyperparathyroidism are asymptomatic, as was our patient. Hypercalcemia is often discovered incidentally during routine laboratory testing ; hypophosphatemia and increased alkaline phosphatase levels in blood may also be seen. " These metabolic changes were detected in our patient.
Parathyroid adenomas are usually sma ll and almost never palpable in the neck . When clin ical manifestations are present, the signs and symptoms can be divided into two types : urologic changes secondary to hypercalcemia and skeletal changes . Urologic changes include polyuria, polydipsia, and the development of kidne y stones . Aga in, hypercalcemia is usuall y asymptomatic, but in severe cases it may cause anorexia, vomiting, constipation, fatigue, weight loss, muscle weakness, psych iatric symptoms, and pancreatitis.' Skeletal changes may represent the first manifestations of the disease , with a loss of cortical bone and an increase in trabecular bone . Bone pain and arthralgia are the most common symptoms. Bone demineralization is uncomm on in mild hyperparathyroidism, but cystic fibrous osteitis is detected in some cases along with pathologic fractures and brow n tumo rs. Radiologically, parathyroid adenomas may or may not exhibit well -defined margins; they may also cause cortical expansions associated with lytic lesions. Finally, patients may exhibit hyperparathyroidism-induced bone changes, such as medullary bone demineralization of the mandible."
Brown tumors exhib it no pathognomonic histologic changes . Examination will reveal a dense fibroblastic stroma, areas of cystic degeneration, osteoid , microfractures, hemorrhage, macrophages with hemosiderin, and multinucleated osteoclastic giant cells . Hemorrhage and hemosiderin confer the lesion's characteristic color. Similar changes may occur in fibrous dyspla sia, true giant-cell tumors, and reparative granulomas.' Differentiating between a brown tumor and other giant-cell tumors may be very difficult, even with histology.
Fibrous dysplasia affects the bones of the face, and it is most common among young women. Histo logy 'reveals trabecu lar bone with a stroma rich in fibrous tissue and multinucleated giant cells that are visible in areas of hemorrhage secon dary to focal degeneration.'?
True giant-cell tumors are more infiltrative than brown tumors. Their cause is unknown. They are rare, but when they do occur, they usually deve lop in older patie nts and they primarily involve the long bones . They also have a tendency to recur. Because of their infiltrative nature, true giant-cell tumors are difficu lt to remove surgically. Histologic analysis reveals giant cells around a fibrous stroma and some degree of cellular atypia.':"
Reparative granulomas are localized tumors detected in young patients. They primar ily involve the mandible. The ir cause is still unkno wn, but some investigators believe that they are a result of trauma.' They can be easily removed by curettage or local excision. A reparative granuloma can be differentiated from a brown tumor by the absence of hyperp arathyroidism. Histologically, they conta in giant cells , but their stroma is less dense and more vascularized.t'?Therefore, patients with giant-cell tumors should be investigated for the presence of hyperparathyroidism and hypercalcemia in order to differentiate these granulomas from brown tumors . Our pat ient was tested for hyperparathyroidism and hypercalcemia only during her second episo de. 434 The initial treatment ofbrown tumor involves control of hyperparathyroidism, regardless of whether it is primary or secondary. Treatment of primary hyperparathyroidism requires a parathyroidectomy. Once hyperparathyroidism is controlled, the tumor tends to regress , although in some cases surgical removal is necess ary, espec ially for patients who have large, symptomatic tumors. Our patient required surgical remova l. Brown tumor can recur ifhyperparathyroidism persists or recurs . ' .
